clinical trials in special populations

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/37

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:59 PM on 5/22/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

38 Terms

1
New cards

What is a clinical trial?

A clinical trial is a carefully designed scientific study conducted in humans to evaluate:

  • Safety

  • Efficacy

  • Side effects

  • Optimal dosing

  • Pharmacokinetics

  • Pharmacodynamics

of medicines, treatments, or interventions.

2
New cards

Why are clinical trials important?

  • Determine whether drugs are safe

  • Establish whether treatments are effective

  • Identify side effects and toxicities

  • Help determine correct dosing

  • Protect patients from harmful or ineffective medicines

3
New cards

What happens during preclinical research?

Before human testing, drugs undergo:

  • Laboratory testing

  • Animal testing

Researchers study:

  • Toxicity

  • Mechanism of action

  • Pharmacokinetics

  • Biological activity

4
New cards

What is the primary purpose of Phase I clinical trials?

Phase I trials primarily assess:

  • Safety

  • Tolerability

  • Pharmacokinetics

  • Pharmacodynamics

5
New cards

How many participants are usually involved in Phase I trials?

20–100 healthy volunteers

6
New cards

What pharmacokinetic factors are studied in Phase I trials?

Researchers investigate:

  • Absorption

  • Distribution

  • Metabolism

  • Excretion

(ADME)

7
New cards

What is pharmacodynamics?

  • The biological and physiological effects of a drug

  • How the drug affects the body

8
New cards

What is dose escalation in Phase I trials?

Dose escalation involves gradually increasing drug doses to:

  • Determine maximum tolerated dose

  • Identify toxicity thresholds

  • Establish safe dosage ranges

9
New cards

Why are side effects carefully monitored in Phase I trials?

Because the drug is being tested in humans for the first time, researchers must identify:

  • Toxic effects

  • Organ damage

  • Adverse reactions

  • Safety concerns

10
New cards

What is the purpose of Phase II clinical trials?

  • Drug efficacy

  • Optimal dosing

  • Continued safety monitoring

11
New cards

How many participants are usually involved in Phase II trials?

100–300 patients

12
New cards

Why do many drugs fail during Phase II trials?

  • Insufficient effectiveness

  • Toxicity

  • Poor pharmacokinetics

  • Unacceptable side effects

13
New cards

What is the purpose of Phase III clinical trials?

  • Efficacy

  • Long-term safety

  • Comparison with existing treatments

14
New cards

How many participants are involved in Phase III trials?

Hundreds to thousands of patients

15
New cards

What is randomisation in clinical trials?

participants are assigned randomly to treatment groups.

  • Reduce bias

  • Improve reliability of results

16
New cards

What is double-blinding?

Neither participants nor researchers know which treatment is being administered.

This reduces:

  • Expectation bias

  • Observer bias

17
New cards

Why are control groups used in Phase III trials?

Control groups allow comparison against:

  • Placebo

  • Standard treatment

This helps determine true drug effectiveness.

18
New cards

Why are Phase III trials important for drug approval?

Data from Phase III trials is submitted to regulatory authorities to determine whether the drug can be licensed for public use.

19
New cards

What are Phase IV clinical trials?

Post-marketing surveillance studies conducted after a drug has been approved.

20
New cards

Why are Phase IV trials necessary?

Some side effects are:

  • Rare

  • Long-term

  • Only visible in very large populations

These may not appear during earlier trial phases.

21
New cards

What is monitored during Phase IV trials?

  • Long-term safety

  • Rare adverse effects

  • Real-world effectiveness

  • Drug interactions

22
New cards

What are special patient populations?

Special patient populations are groups who differ physiologically from healthy adults.

Examples include:

  • Children

  • Elderly patients

  • Pregnant women

  • Breastfeeding women

23
New cards

Why are special populations important in clinical research

These groups often have:

  • Different pharmacokinetics

  • Different pharmacodynamics

  • Different physiology

Therefore adult trial data may not apply accurately

24
New cards

How does gastric pH differ in newborns?

Newborns have:

  • Higher gastric pH (less acidic stomach)

This alters absorption of some medicines.

25
New cards

How does body water content differ in infants?

infants have:

  • Higher total body water percentage

This affects distribution of hydrophilic drugs.

26
New cards

Why is renal excretion reduced in neonates?

kidney function is immature at birth.

This reduces:

  • Drug clearance

  • Excretion capacity

increasing toxicity risk.

27
New cards

Why are paediatric clinical trials necessary?

  • Determine safe dosing

  • Assess efficacy

  • Study side effects

  • Develop child-specific formulations

28
New cards

Why are elderly patients important in clinical research?

  • Carry most disease burden

  • Use large numbers of medications

  • Frequently experience chronic illness

29
New cards

What is polypharmacy?

Use of multiple medications simultaneously

30
New cards

Why is polypharmacy dangerous?

Polypharmacy increases risk of:

  • Drug interactions

  • Adverse effects

  • Medication errors

  • Toxicity

31
New cards

What gastrointestinal changes occur with ageing?

  • Reduced gastric acid secretion

  • Slower gastric emptying

  • Reduced intestinal motility

32
New cards

How does ageing affect body composition?

  • Increased body fat

  • Reduced lean muscle mass

  • Reduced total body water

33
New cards

How does increased body fat affect lipophilic drugs?

Lipophilic drugs distribute into fat stores more extensively.

This increases:

  • Volume of distribution

  • Drug half-life

34
New cards

How does ageing affect liver metabolism?

Ageing causes:

  • Reduced liver size

  • Reduced hepatic blood flow

This slows drug metabolism.

35
New cards

What happens to first-pass metabolism in elderly patients?

First-pass metabolism decreases approximately 1% per year after age 40

This may increase circulating drug levels.

36
New cards

How does kidney function change with age?

  • Reduced nephron number

  • Reduced renal blood flow

  • Reduced glomerular filtration

leading to decreased drug clearance.

37
New cards

Why may elderly patients require lower drug doses?

Because reduced metabolism and excretion can cause:

  • Drug accumulation

  • Toxicity

  • Prolonged drug action

38
New cards

Why do pregnant women require specific clinical research?

Pregnancy alters:

  • Blood volume

  • Hormone levels

  • Renal function

  • Drug metabolism